NCT04271280

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 9,559 (actual)
• Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

High and Very High Risk cardiovascular patient journeys seems to vary from country to country, and current understanding of the process is incomplete. This real-life observational study which documents meaningful patient journey-related parameters can be expected to provide meaningful insight into the care process, country-by-country.

Detailed description

Suffering from hypercholesterolemia is a major health concern in Europe. Appropriate medical treatment lowers low density lipoprotein cholesterol and reduces the incidence of clinical cardiovascular events. Despite the multiple available treatments, many patients remain inadequately treated or even untreated and some lipid-lowering drugs may be associated with an increase in events like side effects or increase in diabetes. As this is a non-interventional study, only data from routine clinical practice will be documented.

Conditions

• Dyslipidemia
• Cardiovascular Diseases
• Hypercholesterolemia
• Atherosclerotic Cardiovascular Disease

Interventions

Type	Name	Description
OTHER	Non-interventional	This is a non-interventional study.

Timeline

• Start date: 2020-03-17
• Primary completion: 2022-04-11
• Completion: 2022-04-11
• First posted: 2020-02-17
• Last updated: 2024-02-20
• Results posted: 2024-02-20

Locations

540 sites across 14 countries: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom